Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Original Article

R. Furie, B.H. Rovin, F. Houssiau, A. Malvar, Y.O. Teng, G. Contreras, Z. Amoura, X. Yu, C.-C. Mok, M.B. Santiago, A. Saxena, Y. Green, B. Ji, C. Kleoudis, S.W. Burriss, C. Barnett, and D.A. Roth

N Engl J Med 2020;383:1117-1128

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
09/16/2020
Course expires: 
09/17/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, September 17, 2022 - 11:59pm.